CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

Journal of Experimental Medicine

Volumn 188, Issue 8, 1998, Pages 1529-1534

  Spada, Franca M ^a   Koezuka, Yasuhiko ^b   Porcelli, Steven A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Pharmaceutical Research Laboratory   (Japan)

Author keywords

Antigen presentation; CD1; Glycolipid; Human; Natural killer T cell

Indexed keywords

CD1 ANTIGEN; CYTOKINE; GLYCOLIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SPHINGOSINE DERIVATIVE; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENDOSOME; HUMAN; HUMAN CELL; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; GLYCOLIPIDS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE;

EID: 0032547823     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.8.1529     Document Type: Article

References (27)

1. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
2. - T cells in mice and humans. J. Exp. Med. 180:1097-1106.
3. + T-cell antigen receptor α chain in mice. Proc. Natl. Acad. Sci. USA. 88:7518-7522.
4. - T cells. J. Exp. Med. 186:109-120.
5. Prussin, C., and B. Foster. 1997. TCR Vα24 and Vβ11 co-expression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J. Immunol. 159:5862-5870.
6. Davodeau, F., M.-A. Peyrat, A. Necker, R. Dominici, F. Blanchard, C. Leget, J. Gaschet, P. Costa, Y. Jacques, A. Godard, et al. 1997. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains. J. Immunol. 158:5603-5611.
7. - T cells. J. Exp. Med. 180:1171-1176.
8. - and heterogeneous with respect to TCRβ expression. Hum. Immunol. 48:63-67.
9. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159:2240-2249.
10. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623-1626.
11. Wilson, S.B., S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, et al. 1998. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 391:177-181.
12. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035-4040.
13. Sumida, T., A. Sakamoto, H. Murata, Y. Makino, H. Takahashi, S. Yoshida, K. Nishioka, I. Iwamoto, and M. Taniguchi. 1995. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182:1163-1168.
14. + T lymphocytes. Science. 268:863-865.
15. + T cells. Nature. 372:691-694.
16. Moody, D.B., B.B. Reinhold, M.R. Guy, E.M. Beckman, D.E. Frederique, S.T. Furlong, S. Ye, V.N. Reinhold, P.A. Sieling, R.L. Modlin, et al. 1997. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 278:283-286.
17. Sieling, P.A., D. Chatterjee, S.A. Porcelli, T.I. Prigozy, R.J. Mazzaccaro, T. Soriano, B.R. Bloom, M.B. Brenner, M. Kronenberg, and P.J. Brennan. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science. 269: 227-230.
18. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 278:1626-1629.
19. Karlsson, K.-A. 1982. Glycosphingolipids and surface membranes. In Biological Membranes. D. Chapman, editor. Academic Press, London. 1-74.
20. Jackman, R.M., S. Stenger, A. Lee, D.B. Moody, R.A. Rogers, K.R. Niazi, M. Sugita, R.L. Modlin, P.J. Peters, and S.A. Porcelli. 1998. The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity. 8:341-351.
21. Beckman, E.M., A. Melian, S.M. Behar, P.A. Sieling, D. Chatterjee, S.T. Furlong, R. Matsumoto, J.P. Rosat, R.L. Modlin, and S.A. Porcelli. 1996. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J. Immunol. 157:2795-2803.
22. Brodsky, P.M., and P. Parham. 1982. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J. Immunol. 128:129-135.
23. Panchamoorthy, G., J. McClean, R.L. Modlin, C.T. Morita, S. Ishikawa, M.B. Brenner, and H. Band. 1991. A predominance of the T cell receptor Vγ2/Vδ2 subset in human mycobacteria-responsive T cells suggests germline encoded recognition. J. Immunol. 147:3360-3369.
24. Porcelli, S. 1995. The CD1 family: a third lineage of antigen presenting molecules. Adv. Immunol. 59:1-98.
25. Jenkins, M.K., and R.H. Schwartz. 1998. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302-319.
26. + T cells upon NKR-P1 cross-linking. J. Exp. Med. 183:2391-2396.
27. + T cell-defective IL-4 production in the non-obese diabetic mouse. Int. Immunol. 8:1751-1758.